141 related articles for article (PubMed ID: 3431051)
1. [Use of anturan in patients with ischemic heart disease with a history of acute myocardial infarction].
Bokarev IN; Golikov AP; Liusov VA; Ptushkin VV; Zvereva TV
Klin Med (Mosk); 1987 Oct; 65(10):29-32. PubMed ID: 3431051
[No Abstract] [Full Text] [Related]
2. [The Anturan reinfarct study].
Sherry S
Wien Med Wochenschr Suppl; 1980; 61():17-22. PubMed ID: 6930766
[No Abstract] [Full Text] [Related]
3. [Anti-aggregation therapy of patients with ischemic heart disease].
Liusov VA; Savenkov MP
Ter Arkh; 1988; 60(8):55-9. PubMed ID: 3227479
[No Abstract] [Full Text] [Related]
4. [Extracorporeal regulation of platelet aggregation in acute myocardial infarction].
Klimovich LG; Gavrilov AO; Grachev SP; Lekokhmaker SS; Bezprozvannyĭ AB
Sov Med; 1989; (9):10-5. PubMed ID: 2603021
[No Abstract] [Full Text] [Related]
5. [Incidence of thrombosis and the status of coagulation in ischaemic heart disease].
Gormsen J; Andersen LA
Ugeskr Laeger; 1974 Dec; 136(49):2727-35. PubMed ID: 4446097
[No Abstract] [Full Text] [Related]
6. [Prophylactic value of platelet anti-aggregants in coronary disease].
Verstraete M
Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
[No Abstract] [Full Text] [Related]
7. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Shalaev SV
Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
[No Abstract] [Full Text] [Related]
8. Clopidogrel resistance--the cardiologist's perspective.
Fefer P; Hod H; Matetzky S
Platelets; 2007 May; 18(3):175-81. PubMed ID: 17497429
[TBL] [Abstract][Full Text] [Related]
9. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
Croveri G
Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
[No Abstract] [Full Text] [Related]
10. Clinical trials of uric acid lowering for coronary heart disease risk reduction.
Simon JA
Am J Med; 2006 Apr; 119(4):e5; author reply e7. PubMed ID: 16564763
[No Abstract] [Full Text] [Related]
11. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Polli EE; Cortellaro M
Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
[No Abstract] [Full Text] [Related]
12. Trials of antiplatelet drugs: some methodological considerations.
Armitage P
Rev Epidemiol Sante Publique; 1979 Sep; 27(2):87-90. PubMed ID: 538303
[No Abstract] [Full Text] [Related]
13. Antiplatelet therapy in coronary heart disease. Emerging strategies for the treatment and prevention of acute myocardial infarction.
Becker RC
Arch Pathol Lab Med; 1993 Jan; 117(1):89-96. PubMed ID: 8418769
[TBL] [Abstract][Full Text] [Related]
14. Platelet aggregation and atherosclerosis.
Valladares BK; Lemberg L
Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitors of thrombocytic function for prophylaxis of coronary heart disease (author's transl)].
Loew D; Breddin K; Uberla K
MMW Munch Med Wochenschr; 1982 Jan; 124(1):46-56. PubMed ID: 6120454
[No Abstract] [Full Text] [Related]
17. [Nitro derivatives: considerations on their antiplatelet activity].
Carella G; Mazzone M; Burrai I; Carbone L; Siciliano M
Clin Ter; 2000; 151(5):345-7. PubMed ID: 11141717
[TBL] [Abstract][Full Text] [Related]
18. [Current clinical results of antiplatelet medication].
Ordinas A
Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
[No Abstract] [Full Text] [Related]
19. [Evaluation of antithrombin III activity in ischemic cardiopathy: changes due to treatment with platelet anti-aggregants].
Avellone G; Mandalà V; Novo S; Davì G; Pinto A; Riolo FP
Boll Soc Ital Cardiol; 1979; 24(11):1229-33. PubMed ID: 261907
[No Abstract] [Full Text] [Related]
20. [Treatment of retinal vein occlusions by a platelet antiaggregant: sulfinpyrazone (Anturan 200)].
Constantinides G; Philibert P
Bull Soc Ophtalmol Fr; 1986; 86(6-7):913-5. PubMed ID: 3829271
[No Abstract] [Full Text] [Related]
[Next] [New Search]
